The drug is a fusion protein comprising the human interleukin (IL)-1 type 1 receptor (extracellular domain and accessory protein) and the Fc portion of human IgG1. Regeneron's drug is the only ...

GNSC-001 is an investigational, adeno-associated virus gene therapy expressing an optimized form of interleukin-1 receptor antagonist (IL-1Ra), a protein that blocks interleukin-1 (IL-1) signaling. IL ...